Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Bempedoic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 925Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daiichi Starts Development of Oral Triple Lipid-Lowering Combo
    Daiichi Starts Development of Oral Triple Lipid-Lowering Combo

    31 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250830562434/en/Daiichi-Sankyo-Announces-the-Initiation-of-the-Development-of-Oral-Triple-Combination-Lipid-Lowering-Tablets-to-Support-the-Management-of-LDL-C

    BUSINESSWIRE
    31 Aug 2025
    Share Share
    Esperion (ESPR) Reaches Settlement to Protect Nexletol Patents
    Esperion (ESPR) Reaches Settlement to Protect Nexletol Patents

    02 Jun 2025

    // GURUFOCUS

    https://www.gurufocus.com/news/2901186/esperion-espr-reaches-settlement-to-protect-nexletol-patents-espr-stock-news

    GURUFOCUS
    02 Jun 2025
    Share Share
    MILOS Study Highlights Bempedoic Acid's Potential In Dyslipidemia
    MILOS Study Highlights Bempedoic Acid's Potential In Dyslipidemia

    11 Oct 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/milos-study-highlights-potential-of-bempedoic-acid-to-advance-dyslipidemia-treatment-globaldata/

    EXPRESSPHARMA
    11 Oct 2024
    Share Share
    MILOS German Cohort Results Show Increase In LDL-C Goal With
    MILOS German Cohort Results Show Increase In LDL-C Goal With

    27 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240926678909/en

    BUSINESSWIRE
    27 Sep 2024
    Share Share
    Bempedoic Acid Cut CVD Risk Across Patient Groups Per CLEAR Outcomes
    Bempedoic Acid Cut CVD Risk Across Patient Groups Per CLEAR Outcomes

    29 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240523300818/en

    BUSINESSWIRE
    29 May 2024
    Share Share
    NILEMDO, NUSTENDI Approved In EU For Cholesterol Lowering
    NILEMDO, NUSTENDI Approved In EU For Cholesterol Lowering

    22 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240514593487/en

    BUSINESSWIRE
    22 May 2024
    Share Share